Maleimidocysteineamido-DOTA Derivatives: New Reagents for Radiometal Chelate Conjugation to Antibody Sulfhydryl Groups Undergo pH-Dependent Cleavage Reactions
- 1 January 1998
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 9 (1), 72-86
- https://doi.org/10.1021/bc970136v
Abstract
We have synthesized two bifunctional derivatives of the macrocyclic chelating agent 1,4,7,10-tetraazacyclododecane-N,N',N",N"-tetraacetic acid (DOTA) equipped with maleimide groups for conjugation to reduced disulfide bonds of monoclonal antibodies. Using water-soluble carbodiimide chemistry, DOTA was coupled to L-cysteine to incorporate both a "pendant-type" carboxyl group for metal coordination and an orthogonal thiol group for protein attachment. The homobifunctional reagent 1,6-bis(maleimido)hexane was then used to introduce the maleimide functionality via a sulfide linkage to the macrocycle, and alternatively, the sulfide group was converted to a sulfone side chain. Both maleimide derivatives were conjugated to the anticarcinoembryonic antigen chimeric monoclonal antibody cT84.66 after light reduction of the mAb with dithiothreitol. In this manner, antibody conjugates were prepared which afforded near-quantitative labeling with the radiometals 111In(III) and 90Y(III) as well as quantitative immunoreactivity. Radioimmunoconjugates prepared with the sulfide and sulfone compounds exhibited relatively rapid linker-dependent radiometal loss when incubated in human serum and aqueous solutions at physiological temperature and pH. The unconjugated maleimidocysteineamido-DOTA derivatives and their Y(III) complexes were incubated in aqueous solution at 37 degrees C, and the resulting decomposition products were analyzed by HPLC and mass spectrometry. These studies revealed that the two bifunctional chelating agents underwent linker-specific cleavage reactions which were considerably faster at pH 7.4 than at pH 5.4. The chemically labile linker systems are expected to release chelated radiometal from mAb conjugates in a pH-dependent manner. This property may impart favorable tumor uptake and normal tissue clearance on radioimmunoconjugates prepared with these reagents, on the basis of the observation that many solid tumors are significantly more acidic than normal tissues.Keywords
This publication has 17 references indexed in Scilit:
- Biodistribution of 111In- and 90Y-Labeled DOTA and Maleimidocysteineamido-DOTA Conjugated to Chimeric Anticarcinoembryonic Antigen Antibody in Xenograft-Bearing Nude Mice: Comparison of Stable and Chemically Labile Linker SystemsBioconjugate Chemistry, 1998
- A Facile, Water-Soluble Method for Modification of Proteins with DOTA. Use of Elevated Temperature and Optimized pH To Achieve High Specific Activity and High Chelate Stability in Radiolabeled ImmunoconjugatesBioconjugate Chemistry, 1994
- A kinetic investigation of the lanthanide DOTA chelates. Stability and rates of formation and of dissociation of a macrocyclic gadolinium(III) polyaza polycarboxylic MRI contrast agentInorganic Chemistry, 1992
- Thermodynamic and kinetic studies of lanthanide complexes of 1,4,7,10,13-pentaazacyclopentadecane-N,N',N'',N''',N''''-pentaacetic acid and 1,4,7,10,13,16-hexaazacyclooctadecane-N,N',N'',N''',N'''',N'''''-hexaacetic acidInorganic Chemistry, 1991
- Carboxymethyl-substituted bifunctional chelators: preparation of arylisothiocyanate derivatives of 3-(carboxymethyl)-3-azapentanedioic acid, 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, and 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid for use as protein labelsBioconjugate Chemistry, 1991
- Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targetingJournal of Medicinal Chemistry, 1989
- An efficient method for labelling antibodies with 111InFEBS Letters, 1984
- Tumour pH in human mammary carcinomaEuropean Journal of Cancer and Clinical Oncology, 1982
- N-(1-Pyrene)maleimide: a fluorescent crosslinking reagentBiochemistry, 1976
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965